SMS Pharmaceuticals informs about updates

22 Mar 2025 Evaluate

SMS Pharmaceuticals has informed, the United States Food and Drug Administration (USFDA) has conducted an inspection of the Company’s Active Pharmaceutical Ingredient (API) manufacturing facility located at Bachupally, Hyderabad, Telangana, it has the enclosed Company statement titled ‘Successful completion of USFDA inspection at Hyderabad facility’. The above information will also be made available on the website of the Company at www.smspharma.com.

The above information is a part of company’s filings submitted to BSE.


SMS Pharmaceuticals Share Price

212.70 3.60 (1.72%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...